Phase 2 Study Shows Rozanolixizumab Is Safe and Effective in Alleviating MG Symptoms
Investigational antibody rozanolixizumab (UCB7665) has proven safe and effective in treating symptoms associated with myasthenia gravis…
Get regular updates to your inbox.